ASP Isotopes Sees Unusually High Options Volume (NASDAQ:ASPI)
by Doug Wharley · The Cerbat GemASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) saw unusually large options trading activity on Tuesday. Investors bought 15,098 call options on the company. This represents an increase of approximately 65% compared to the average daily volume of 9,140 call options.
Insiders Place Their Bets
In other ASP Isotopes news, CFO Heather Kiessling sold 23,124 shares of the company’s stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $5.48, for a total transaction of $126,719.52. Following the completion of the transaction, the chief financial officer owned 709,376 shares in the company, valued at approximately $3,887,380.48. This represents a 3.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Robert Ainscow sold 25,000 shares of the company’s stock in a transaction on Friday, March 6th. The stock was sold at an average price of $4.51, for a total transaction of $112,750.00. Following the transaction, the chief operating officer owned 1,512,817 shares of the company’s stock, valued at approximately $6,822,804.67. The trade was a 1.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 90,704 shares of company stock worth $463,252. 14.40% of the stock is owned by insiders.
Institutional Investors Weigh In On ASP Isotopes
Large investors have recently added to or reduced their stakes in the business. State of Wyoming acquired a new stake in ASP Isotopes in the 1st quarter valued at about $29,000. Quantbot Technologies LP acquired a new stake in ASP Isotopes in the 3rd quarter valued at about $34,000. BNP Paribas Financial Markets grew its stake in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after acquiring an additional 2,548 shares during the last quarter. Stephens Inc. AR acquired a new stake in ASP Isotopes in the 1st quarter valued at about $44,000. Finally, Broadhurst Jeffrey B acquired a new stake in ASP Isotopes in the 1st quarter valued at about $44,000. 16.80% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts have commented on ASPI shares. Canaccord Genuity Group restated a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $13.00.
Check Out Our Latest Report on ASPI
ASP Isotopes Price Performance
Shares of NASDAQ:ASPI traded up $1.09 on Tuesday, reaching $6.64. 7,794,652 shares of the company were exchanged, compared to its average volume of 4,999,316. The company has a current ratio of 4.39, a quick ratio of 12.20 and a debt-to-equity ratio of 0.69. ASP Isotopes has a 1-year low of $3.92 and a 1-year high of $14.49. The firm has a market cap of $835.98 million, a price-to-earnings ratio of -3.19 and a beta of 3.26. The company has a 50-day moving average of $5.06 and a 200-day moving average of $5.91.
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last posted its quarterly earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.06. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%. The business had revenue of $8.36 million for the quarter, compared to analysts’ expectations of $3.68 million.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.